These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10426368)

  • 1. Interleukin-13 prevents autoimmune diabetes in NOD mice.
    Zaccone P; Phillips J; Conget I; Gomis R; Haskins K; Minty A; Bendtzen K; Cooke A; Nicoletti F
    Diabetes; 1999 Aug; 48(8):1522-8. PubMed ID: 10426368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
    Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice.
    Xiang M; Zaccone P; Di Marco R; Harris R; Magro G; Di Mauro M; Meroni PL; Garotta G; Nicoletti F
    Autoimmunity; 1999; 30(2):71-80. PubMed ID: 10435719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
    Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
    J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
    Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
    Panerai AE; Nicoletti F; Sacedote P; Arvidsson L; Conget I; Gomis R; Bartorelli A; Sandler S
    Diabetologia; 2001 Jul; 44(7):839-47. PubMed ID: 11508268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
    Rabinovitch A; Suarez-Pinzon WL; Shapiro AM; Rajotte RV; Power R
    Diabetes; 2002 Mar; 51(3):638-45. PubMed ID: 11872661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
    Zhang J; Huang Z; Sun R; Tian Z; Wei H
    J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells.
    Papaccio G; Nicoletti F; Pisanti FA; Bendtzen K; Galdieri M
    Endocrinology; 2000 Apr; 141(4):1500-5. PubMed ID: 10746656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10.
    Faust A; Rothe H; Schade U; Lampeter E; Kolb H
    Transplantation; 1996 Sep; 62(5):648-52. PubMed ID: 8830831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
    Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice.
    Fujihira K; Nagata M; Moriyama H; Yasuda H; Arisawa K; Nakayama M; Maeda S; Kasuga M; Okumura K; Yagita H; Yokono K
    Diabetes; 2000 Dec; 49(12):1998-2006. PubMed ID: 11118000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
    Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
    Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
    Liang L; Beshay E; Prud'homme GJ
    Diabetes; 1998 Apr; 47(4):570-5. PubMed ID: 9568689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
    Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
    Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
    Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
    J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.